Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Masison Website

Cynthia A. Masison, Ph.D.

Selected Publications

1)  Liyanage NP, Gordon SN, Doster MN, Pegu P, Vaccari M, Shukur N, Schifanella L, Pise-Masison CA, Lipinska D, Grubczak K, Moniuszko M, Franchini G.
Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac251 infection of macaques.
Virology. 450-451: 359-68, 2014.
2)  Chevalier SA, Turpin J, Cachat A, Afonso PV, Gessain A, Brady JN, Pise-Masison CA, Mahieux R.
Gem-induced cytoskeleton remodeling increases cellular migration of HTLV-1-infected cells, formation of infected-to-target T-cell conjugates and viral transmission.
PLoS Pathog. 10: e1003917, 2014.
3)  Fenizia C, Fiocchi M, Jones K, Parks RW, Ceribelli M, Chevalier SA, Edwards D, Ruscetti F, Pise-Masison CA, Franchini G.
Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells.
J. Virol. 88: 393-402, 2014.
4)  Chen J, Pise-Masison CA, Shih JH, Morris JC, Janik JE, Conlon KC, Keating A, Waldmann TA.
Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia.
Blood. 121: 2029-37, 2013.
5)  Chevalier SA, Durand S, Dasgupta A, Radonovich M, Cimarelli A, Brady JN, Mahieux R, Pise-Masison CA.
The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties.
PLoS ONE. 7: e41003, 2012.
6)  Edwards DC, McKinnon KM, Fenizia C, Jung KJ, Brady JN, Pise-Masison CA.
Inhibition of geranylgeranyl transferase-I decreases cell viability of HTLV-1-transformed cells.
Viruses. 3: 1815-35, 2011.
7)  Edwards D, Fenizia C, Gold H, de Castro-Amarante MF, Buchmann C, Pise-Masison CA, Franchini G.
Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence.
Viruses. 3: 861-85, 2011.
8)  Andresen V, Pise-Masison CA, Sinha-Datta U, Bellon M, Valeri V, Washington Parks R, Cecchinato V, Fukumoto R, Nicot C, Franchini G.
Suppression of HTLV-1 replication by Tax-mediated re-routing of the p13 viral protein to nuclear speckles.
Blood. 118: 1549-59, 2011.
9)  Van Prooyen N, Andresen V, Gold H, Bialuk I, Pise-Masison C, Franchini G.
Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.
Mol. Aspects Med. 31: 333-43, 2010.
10)  Cho WK, Jang MK, Huang K, Pise-Masison CA, Brady JN.
Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding.
J. Virol. 84: 12801-9, 2010.
Click Here to View Expanded Bibliography.

This page was last updated on 4/10/2014.